Abstract
Abstract In this article, the new developments on the platinum‐based anticancer drugs mainly in the past decade were remarked and discussed. These include the new research progress and insights on the classical platinum drugs, such as cisplatin and oxaliplatin, as well as the recent research progress on those nonclassical platinum‐based drugs. Especially, we focused on the emerging studies on the polynuclear platinum complexes, platinum(IV) complexes, and the photodynamic therapy and nanocarrier systems of these new types of platinum complexes. We have tried to select the most representative ones to be emphasized so that the most significant research progress of the platinum drugs may be shown and reported. This will inspire more scientists to develop better and more promising platinum‐based drugs based on these research findings in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
